Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Hanson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 15, 2006
Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosalVijendra K Singh, Jeff Hanson
Cell and Tissue Banking|March 28, 2007
Quality control of human tissues--experience from the Indiana University Cancer Center-Lilly Research Labs human tissue bankGeorge E Sandusky, Katie Heinz Teheny, Mike Esterman, et al.
The Journal of Pathology. Clinical Research|September 8, 2018
High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti-CD74-drug conjugateShuchun Zhao, Arturo Molina, Abigail Yu, et al.
Cancer Research|January 1, 2016
VEGF-A/VEGFR Inhibition Restores Hematopoietic Homeostasis in the Bone Marrow and Attenuates Tumor GrowthRebekah K O'Donnell, Beverly Falcon, Jeff Hanson, et al.
Drug Discovery Today|September 5, 2012
High-content multiplexed tissue imaging and quantification for cancer drug discoveryBeverly L Falcon, Julie Stewart, Scharri Ezell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2009
Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005David W Lowrance, Francois Ndamage, Eugenie Kayirangwa, et al.
Molecular Cancer Therapeutics|April 25, 2015
Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle WastingRosamund C Smith, Martin S Cramer, Pamela J Mitchell, et al.
Plos One|April 22, 2020
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strengthRosamund C Smith, Martin S Cramer, Pamela J Mitchell, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 15, 2006
Assessment of metallothionein and antibodies to metallothionein in normal and autistic children having exposure to vaccine-derived thimerosalVijendra K Singh, Jeff Hanson
Cell and Tissue Banking|March 28, 2007
Quality control of human tissues--experience from the Indiana University Cancer Center-Lilly Research Labs human tissue bankGeorge E Sandusky, Katie Heinz Teheny, Mike Esterman, et al.
The Journal of Pathology. Clinical Research|September 8, 2018
High frequency of CD74 expression in lymphomas: implications for targeted therapy using a novel anti-CD74-drug conjugateShuchun Zhao, Arturo Molina, Abigail Yu, et al.
Cancer Research|January 1, 2016
VEGF-A/VEGFR Inhibition Restores Hematopoietic Homeostasis in the Bone Marrow and Attenuates Tumor GrowthRebekah K O'Donnell, Beverly Falcon, Jeff Hanson, et al.
Drug Discovery Today|September 5, 2012
High-content multiplexed tissue imaging and quantification for cancer drug discoveryBeverly L Falcon, Julie Stewart, Scharri Ezell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 21, 2009
Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005David W Lowrance, Francois Ndamage, Eugenie Kayirangwa, et al.
Molecular Cancer Therapeutics|April 25, 2015
Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle WastingRosamund C Smith, Martin S Cramer, Pamela J Mitchell, et al.
Plos One|April 22, 2020
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strengthRosamund C Smith, Martin S Cramer, Pamela J Mitchell, et al.
Pageof 1